Clinical trials: Hair Problems
Androgenic Alopecia
Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia
Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc.
- Trial name
- NCT03506503
- Testing
- Nanofat grafting
- Where
- China
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Jinan University Guangzhou
Alopecia Areata
Topical Cetirizine in Treatment of Localized Alopecia Areata
Evaluate and compare the efficacy and safety of topical cetirizine 1%, versus topical betamethasone valerate 0.1% in the treatment of localized alopecia areata.
- Trial name
- NCT05803070
- Testing
- Topical Cetirizine 1 %, Topical betamethasone valerate 0.1%
- Volunteers
- 59 people
- Sponsor
- Assiut University
Hair Thinning
Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning Hair
The goal of this study is to determine how safe and effective it is to improve hair growth using XVIE solution applied on the scalp of women with self-perceived thinning hair. The main aims of this trial are: 1.
- Trial name
- NCT07221773
- Testing
- XVIE
- Where
- 2 sites in United States
- Volunteers
- 15 people
- Sponsor
- Restore Biologics Holdings, Inc. dba Xtressé
Kinky Hair Syndrome
Copper Histidine Therapy for Menkes Diseases
Menkes Disease is a genetic disorder affecting the metabolism of copper. Patient with this disease are both physically and mentally retarded. Menkes disease is usually first detected in the first 2-3 months of life.
- Trial name
- NCT00001262
- Testing
- Copper Histidine
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Androgenetic Alopecia
A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia
This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Androgenetic Alopecia. The study is being conducted at 2 centers in India.
- Trial name
- NCT01643629
- Testing
- Autologous Human Platelet Lysate (HPL), 2 % Minoxidil and /or Finasteride
- Where
- India
- Volunteers
- 20 people
- Sponsor
- Kasiak Research Pvt. Ltd.
Androgenic Alopecia
MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)
This randomized clinical trial carried out on 60 Brazilian men, aged 18 to 65, with mild or moderate androgenetic alopecia. Two techniques for administering dutasteride will be compared, injected by syringes or needles or by…
- Trial name
- MMP (NCT06110377)
- Testing
- MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE), MMP (INJECTIONS WITH A TATTOO MACHINE)
- Where
- Brazil
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Clinica Dermatologica Arbache ltda
Folliculitis
Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne Contaminated
The objective of this trial is to evaluate the comparative efficacy of the combination of Clotrimazole + Gentamicin + Beclomethasone in study subjects with a condition of contaminated dermatosis showing bilateral symmetrical…
- Trial name
- acne (NCT01244256)
- Testing
- Clotrimazole + Gentamicin + Beclomethasone, Clotrimazole + Gentamicin
- Where
- Brazil
- Volunteers
- 80 people
- Sponsor
- Azidus Brasil
Excessive Hairiness, Vascular Lesion
Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias.
- Conditions
- Excessive Hairiness, Vascular Lesion, Pigmented Lesions, Acne Vulgaris
- Trial name
- Anthelia (NCT06655129)
- Testing
- intense pulsed light
- Where
- 5 sites in France
- Volunteers
- 85 people, healthy volunteers welcome
- Sponsor
- Eurofeedback
Androgenetic Alopecia, Hair Loss
Treatment of Androgenetic Alopecia in Males
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 7 Beam model in promoting hair growth in males diagnosed with androgenetic alopecia when treatment is applied as directed.
- Conditions
- Androgenetic Alopecia, Hair Loss, Male Pattern Baldness
- Trial name
- NCT00947505
- Testing
- HairMax LaserComb 2009, 7 Beam, HairMax LaserComb
- Where
- 2 sites in United States
- Volunteers
- 49 people, healthy volunteers welcome
- Sponsor
- Lexington International, LLC
Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea, Hypersexuality in Men
A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe
Androcur is a type of treatment called cyproterone acetate (CPA). Androcur and other CPA treatments work by blocking a group of male sex hormones called androgens in the body.
- Conditions
- Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea, Hypersexuality in Men, Sexual Deviations in Men, Prostate Cancer
- Trial name
- Safe-CAM (NCT04925180)
- Testing
- Cyproterone Acetate (Androcur, BAY94-8367)
- Where
- 5 sites in France, Germany and 3 more
- Volunteers
- 600 people
- Sponsor
- Bayer
Androgenetic Alopecia, Female Pattern Baldness
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
The primary objective of the study is to assess the safety and efficacy of DA-005 and DA-002 as a treatment for hair loss (androgenetic alopecia).
- Conditions
- Androgenetic Alopecia, Female Pattern Baldness, Male Pattern Baldness
- Trial name
- NCT06501924
- Testing
- DA-005, Topical minoxidil 5%, DA-002
- Volunteers
- 516 people
- Sponsor
- Applied Biology, Inc.
Hair Thinning
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair
NUTRAFOL® Women's Balance supplement is a novel nutraceutical supplement, scientifically formulated to specifically target the multiple underlying causes of hair loss and thinning in women.
- Trial name
- NCT04048031
- Testing
- Nutrafol Supplement Capsules
- Where
- United States
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Ablon Skin Institute Research Center
Primary Breast Cancer
Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
This is a phase III, single-center, prospective, open-label, randomized,controlled study
- Trial name
- COHAIR (NCT03711877)
- Testing
- Scalp cooling system, Cold cap
- Where
- China
- Volunteers
- 256 people
- Sponsor
- Tao OUYANG
Fat Grafting, Hair Transplantation
Study on the Efficacy of Autologous Fat Grafting in Improving Hair Transplantation Outcomes for Patients With Localized Scleroderma-Related Alopecia
Investigating the efficacy and safety of autologous fat grafting combined with hair transplantation for the treatment of hair loss in patients with localized scleroderma."
- Conditions
- Fat Grafting, Hair Transplantation, Localized Scleroderma
- Trial name
- NCT06646146
- Testing
- Fat grafting combine with hair transplantation, Hair transplantation
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Nanfang Hospital, Southern Medical University
Male Pattern Hair Loss, Androgenetic Alopecia
Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
The objective of this study is to evaluate the safety and efficacy of fractionated ablative 10,600nm CO2 laser assisted delivery of 2% minoxidil solution in the treatment of MPHL.
- Conditions
- Male Pattern Hair Loss, Androgenetic Alopecia, Male Pattern Baldness
- Trial name
- NCT03852992
- Testing
- Post-Laser Minoxidil 2%, At-Home Minoxidil 5%, Laser
- Where
- United States
- Sponsor
- University of Minnesota
Androgenic Alopecia
Computer-Assisted Hair Restoration Study Using ARTAS System
Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.
- Trial name
- NCT05938569
- Testing
- Hair restoration
- Where
- 2 sites in United States
- Volunteers
- 150 people
- Sponsor
- Venus Concept
Alopecia
Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy
The purpose of this study is to determine if MTS-01 is effective in preventing radiotherapy-induced hair loss in patients receiving whole brain radiotherapy
- Trial name
- NCT00713154
- Testing
- MTS-01
- Volunteers
- 16 people
- Sponsor
- Mitos Pharmaceuticals
Alopecia Areata
Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
Compare the clinical efficacy, and safety of transepidermal drug delivery of fractional CO2 laser versus microneedling followed by minoxidil 5% application for the treatment of alopecia areata.
- Trial name
- NCT05587257
- Testing
- Fractional CO2 laser, Derma pen, Niosome minoxidil
- Volunteers
- 60 people
- Sponsor
- Assiut University
Androgenetic Alopecia
Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia
Microneedling and autologous concentrated growth factor (CGF) have established their potential effect in inducing hair regrowth.
- Trial name
- NCT06218394
- Testing
- microneedling, Autologous Concentrated Growth Factor, 5% minoxidil
- Where
- China
- Volunteers
- 135 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Alopecia Areata
A Study of Secukinumab for the Treatment of Alopecia Areata
Alopecia areata is a medical condition, in which the hair falls out in patches. The hair can fall out on the scalp or elsewhere on the face and body.
- Trial name
- NCT02599129
- Testing
- Secukinumab
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- Icahn School of Medicine at Mount Sinai